In a report released today, Matthew O’Brien from Piper Sandler maintained a Buy rating on Integer Holdings (ITGR – Research Report), with a ...

Full Year 2024 Results Key Financial Results Revenue: US$1.72b (up 7.5% from FY ...

Principal Financial Group Inc. lifted its stake in shares of Integer Holdings Co. (NYSE:ITGR – Free Report) by 3.9% in the ...

Medical technology company Integer Holdings (NYSE:ITGR) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up ...

Integer Holdings Corporation (NYSE: ITGR), a prominent manufacturer of medical devices, announced its financial performance for the fourth quarter and the full year that ended on December 31, 2024, on ...

Oppenheimer downgraded Integer (ITGR) to Perform from Outperform without a price target following the Q4 report. While “fundamentally ...

Medical technology company Integer Holdings (NYSE:ITGR) will be announcing earnings results tomorrow before market hours.

Q4 2024 Management View CEO Joe Dziedzic announced that Integer Holdings achieved 11% sales growth in Q4 2024 on both an organic and reported basis, contributing to a full-year growth of 10%. Adjusted ...

Learn more about whether Integer Holdings Corporation or NovoCure Limited is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

The Plano, Texas-based company said it had profit of 90 cents per share. Earnings, adjusted for amortization costs and non-recurring costs, came to $1.43 per share. The results missed Wall Street ...